Anti-fap/interleukin-2 Fusion Protein Ro6874281
Anti-fap/interleukin-2 Fusion Protein Ro6874281 Uses, Dosage, Side Effects, Food Interaction and all others data.
Anti-fap/interleukin-2 Fusion Protein Ro6874281 is under investigation in clinical trial NCT03193190 (A Study of Multiple Immunotherapy-based Treatment Combinations in Participants With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-pancreatic Cancer)).
Trade Name | Anti-fap/interleukin-2 Fusion Protein Ro6874281 |
Generic | RO6874281 |
RO6874281 Other Names | Anti-fap/interleukin-2 fusion protein ro6874281, Simlukafusp alfa |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
![Anti-fap/interleukin-2 Fusion Protein Ro6874281 Anti-fap/interleukin-2 Fusion Protein Ro6874281](https://www.medicinesfaq.com/media/png/anti-fapinterleukin-2-fusion-protein-ro6874281.png)
Innovators Monograph
You find simplified version here Anti-fap/interleukin-2 Fusion Protein Ro6874281